DJIA 16,472.37 200.36 1.23%
NASDAQ 4,707.78 80.69 1.74%
S&P 500 1,951.36 27.54 1.43%
market minute promo

Sanofi (ADR) (NYSE: SNY)

company name or ticker
Company Photos
(Click to zoom)

Regeneron and Sanofi Present Encouraging Praluent Data

European ADRs Log Marginal Gains as Pharma Stocks See Mixed Fortunes

Trade-Ideas: Sanofi (SNY) Is Today's Pre-Market Mover With Heavy Volume Stock

Amgen's Next-Generation Cholesterol Drug Is Approved, but Pricing Is a Huge Concern

Repatha gets the green light from the Food and Drug Administration, but pharmacy benefit managers and insurers are ready to give PCSK9 inhibitors the red light.

Sanofi Teams Up with Google Life Sciences for Diabetes

Google, Sanofi to Jointly Improve Diabetes Management

ESC- Case Builds For Jardiance

5 Things MannKind Corporation's Management Team Wants You To Know

Management had a lot of information to share with investors when it reported second quarter earnings. Here are 5 key takeaways.

Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes

Amgen's PCSK9 Inhibitor, Repatha, Approved in the U.S.

See More Articles...